A PHYSICIANS GUIDE TO INFORMATION AVAILABLE FROM THE FDA ABOUT NEW DRUG APPROVALS

被引：0

作者：

HASSALL, TH

FREDD, SB

机构：

来源：

AMERICAN JOURNAL OF GASTROENTEROLOGY | 1989年 / 84卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：1222 / 1226

页数：5

共 50 条

[31] FDA new drug approvals in Q3 2020
Urquhart, Lisa
NATURE REVIEWS DRUG DISCOVERY, 2020, 19 (11) : 746 - 746
[32] FDA new drug approvals in Q2 2022
Lisa Urquhart
Nature Reviews Drug Discovery, 2022, 21 : 550 - 550
[33] FDA new drug approvals in Q2 2018
Urquhart, Lisa
NATURE REVIEWS DRUG DISCOVERY, 2018, 17 (08) : 536 - 537
[34] FDA new drug approvals in Q3 2021
Lisa Urquhart
Nature Reviews Drug Discovery, 2021, 20 : 807 - 807
[35] FDA new drug approvals in Q1 2021
Lisa Urquhart
Nature Reviews Drug Discovery, 2021, 20 : 334 - 334
[36] FDA new drug approvals in Q3 2018
Urquhart, Lisa
NATURE REVIEWS DRUG DISCOVERY, 2018, 17 (11) : 779 - 779
[37] FDA new drug approvals in Q3 2018
Lisa Urquhart
Nature Reviews Drug Discovery, 2018, 17 : 779 - 779
[38] FDA new drug approvals in Q3 2024
Verdin, Paul
NATURE REVIEWS DRUG DISCOVERY, 2024, 23 (11) : 806 - 806
[39] EVALUATING TRENDS IN THE USE OF RWE IN FDA NEW DRUG APPROVALS
York, M.
Franklin, M.
Rojubally, A.
Patel, M.
Gdovin, Bergeson J.
VALUE IN HEALTH, 2024, 27 (06) : S368 - S368
[40] FDA new drug approvals in Q1 2022
Lisa Urquhart
Nature Reviews Drug Discovery, 2022, 21 : 329 - 329